abstract |
The present invention relates to antisense oligonucleotides that regulate the expression and / or function of glial cell-derived neurotrophic factor (GDNF), particularly directed to the natural antisense polynucleotide of glial cell-derived neurotrophic factor (GDNF). The invention also relates to the identification of these antisense oligonucleotides and their use in the treatment of diseases and disorders associated with the expression of GDNF. |